Literature DB >> 31095246

Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification.

Mohamed L Sorror1,2, Barry E Storer3,4, Jennifer Nyland1, Elihu H Estey2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31095246      PMCID： PMC6537840          DOI： 10.1001/jamaoncol.2019.0902

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

Review 1.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

2.  Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.

Authors:  Gary S Collins; Johannes B Reitsma; Douglas G Altman; Karel G M Moons
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

3.  Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies.

Authors:  Ann-Kathrin Eisfeld; Jessica Kohlschmidt; Krzysztof Mrózek; James S Blachly; Christopher J Walker; Deedra Nicolet; Shelley Orwick; Sophia E Maharry; Andrew J Carroll; Richard M Stone; Albert de la Chapelle; Eunice S Wang; Jonathan E Kolitz; Bayard L Powell; John C Byrd; Clara D Bloomfield
Journal:  Leukemia       Date:  2018-02-25       Impact factor: 11.528

4.  Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality.

Authors:  Mohamed L Sorror; Barry E Storer; Amir T Fathi; Aaron T Gerds; Bruno C Medeiros; Paul Shami; Andrew M Brunner; Mikkael A Sekeres; Sudipto Mukherjee; Esteban Peña; Mahmoud Elsawy; Shylo Wardyn; Jennifer Whitten; Rachelle Moore; Pamela S Becker; Jeannine S McCune; Frederick R Appelbaum; Elihu H Estey
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777
  4 in total
  4 in total

1.  Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.

Authors:  Daniel A Pollyea; Amanda Winters; Christine McMahon; Marc Schwartz; Craig T Jordan; Rachel Rabinovitch; Diana Abbott; Clayton A Smith; Jonathan A Gutman
Journal:  Bone Marrow Transplant       Date:  2021-10-13       Impact factor: 5.483

Review 2.  Advances in Management for Older Adults With Hematologic Malignancies.

Authors:  Ashley E Rosko; Raul Cordoba; Gregory Abel; Andrew Artz; Kah Poh Loh; Heidi D Klepin
Journal:  J Clin Oncol       Date:  2021-05-27       Impact factor: 50.717

Review 3.  Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia.

Authors:  Servais Sophie; Beguin Yves; Baron Frédéric
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

4.  Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.

Authors:  Mohamed L Sorror; Barry E Storer; Amir T Fathi; Andrew Brunner; Aaron T Gerds; Mikkael A Sekeres; Sudipto Mukherjee; Bruno C Medeiros; Eunice S Wang; Pankit Vachhani; Paul J Shami; Esteban Peña; Mahmoud Elsawy; Kehinde Adekola; Selina Luger; Maria R Baer; David Rizzieri; Tanya M Wildes; Jamie Koprivnikar; Julie Smith; Mitchell Garrison; Kiarash Kojouri; Wendy Leisenring; Lynn Onstad; Jennifer E Nyland; Pamela S Becker; Jeannine S McCune; Stephanie J Lee; Brenda M Sandmaier; Frederick R Appelbaum; Elihu H Estey
Journal:  Blood       Date:  2021-08-05       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.